“…Studies on alveolarization generally rely on the identification and validation of pathways that direct lung development, using pharmacological and genetic approaches. Small‐molecule and proteinaceous modulators of developmental pathways have been administered via the enteral or parenteral routes, and subsequently, the impact on the development of the lung structure might be assessed microscopically (Valenzuela et al, ) or radiologically (Xiao et al, ); alongside screens for transcriptomic changes (Mariani, ), by microarray, or more recently, RNA‐Seq (Bhattacharya et al, ; Lingappan et al, ) technology. Small‐molecule interventions have, in the past, relied on enzyme inhibitors to block enzyme function (Reviewed in Madurga et al, ; Silva et al, ; Surate Solaligue et al, ); but have recently been expanded to include chemical chaperones (Nguyen and Uhal, ; Siddesha et al, ) and genetic interference, through sequence‐specific modulation of microRNA function using antagomiRs (Nardiello and Morty, ) or microRNA mimics (Olave et al, ; Durrani‐Kolarik et al, ).…”